Akoya Biosciences, Inc.
AKYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $83 | $74 | $113 |
| Short-Term Investments | $23 | $0 | $7 | $0 |
| Receivables | $14 | $17 | $10 | $9 |
| Inventory | $24 | $18 | $14 | $9 |
| Other Curr. Assets | $4 | $4 | $7 | $9 |
| Total Curr. Assets | $77 | $122 | $112 | $141 |
| Property Plant & Equip (Net) | $13 | $21 | $22 | $7 |
| Goodwill | $18 | $18 | $18 | $18 |
| Intangibles | $15 | $17 | $20 | $21 |
| Long-Term Investments | $0 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | -$0 | -$0 |
| Other NC Assets | $2 | $2 | $3 | $3 |
| Total NC Assets | $48 | $59 | $64 | $50 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $125 | $180 | $176 | $191 |
| Liabilities | – | – | – | – |
| Payables | $9 | $12 | $11 | $9 |
| Short-Term Debt | $7 | $3 | $4 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $7 | $7 | $6 | $4 |
| Other Curr. Liab. | $8 | $13 | $17 | $13 |
| Total Curr. Liab. | $29 | $35 | $37 | $28 |
| LT Debt | $81 | $82 | $72 | $33 |
| Deferred Rev, NC | $3 | $3 | $2 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $6 | $6 | $8 |
| Total NC Liab. | $88 | $91 | $80 | $42 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $10 | $13 | $0 |
| Total Liabilities | $117 | $127 | $117 | $70 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $191 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$285 | -$230 | -$167 | -$96 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $293 | $284 | $225 | $27 |
| Total Equity | $8 | $54 | $59 | $121 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $125 | $180 | $176 | $191 |
| Net Debt | $76 | $3 | $2 | -$80 |